DOES SEROTONIN AUGMENTATION HAVE ANY EFFECT ON COGNITION AND ACTIVITIES OF DAILY LIVING IN ALZHEIMER'S DEMENTIA?: A DOUBLE-BLIND CLINICAL TRIAL

被引:0
|
作者
Mowla, A. [1 ]
机构
[1] Bushehr Univ Med Sci, Bushehr, Iran
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
P01-98
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? - A double-blind, placebo-controlled clinical trial
    Mowla, Arash
    Mosavinasab, Masoud
    Haghshenas, Hasan
    Borhani-Haghighi, Afshin
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (05) : 484 - 487
  • [2] Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind placebo-controlled clinical trial
    Borhani-Haghighi, A.
    Mowla, A.
    Mousavinasab, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 48 - 48
  • [3] Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial
    Mowla, Arash
    Mosavinasab, Masoud
    Pani, Azadeh
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (01) : 67 - 70
  • [4] Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran
    Faridhosseini, Farhad
    Talaei, Ali
    Shahini, Najmeh
    Salimi, Zanireh
    Eslamzadeh, Mahboubeh
    Ahrari, Samira
    Pourgholami, Meysam
    Khadem-Rezaiyan, Majid
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (05) : 336 - 341
  • [5] Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
    Doody, Rachelle S.
    Gavrilova, Svetlana I.
    Sano, Mary
    Thomas, Ronald G.
    Aisen, Paul S.
    Bachurin, Sergey O.
    Seely, Lynn
    Hung, David
    LANCET, 2008, 372 (9634): : 207 - 215
  • [6] Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial
    J. B. Deakin
    S. Rahman
    P. J. Nestor
    J. R. Hodges
    B. J. Sahakian
    Psychopharmacology, 2004, 172 : 400 - 408
  • [7] Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial
    Deakin, JB
    Rahman, S
    Nestor, PJ
    Hodges, JR
    Sahakian, BJ
    PSYCHOPHARMACOLOGY, 2004, 172 (04) : 400 - 408
  • [8] The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study
    Chemerinski, E
    Robinson, RG
    Arndt, S
    Kosier, JT
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2001, 189 (07) : 421 - 425
  • [9] Efficacy of Memantine for Agitation in Alzheimer's Dementia: A Randomised Double-Blind Placebo Controlled Trial
    Fox, Chris
    Crugel, Monica
    Maidment, Ian
    Auestad, Bjorn Henrik
    Coulton, Simon
    Treloar, Adrian
    Ballard, Clive
    Boustani, Malaz
    Katona, Cornelius
    Livingston, Gill
    PLOS ONE, 2012, 7 (05):
  • [10] Effects of virtual reality on upper extremity function and activities of daily living performance in acute stroke: A double-blind randomized clinical trial
    Kwon, Jae-Sung
    Park, Mi-Jung
    Yoon, In-Jin
    Park, Soo-Hyun
    NEUROREHABILITATION, 2012, 31 (04) : 379 - 385